federal_register: 2012-19748

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2012-19748 Regulatory New Drug Review: Solutions for Study Data Exchange Standards; Notice of Meeting; Request for Comments Proposed Rule The Food and Drug Administration (FDA) is announcing a meeting entitled "Regulatory New Drug Review: Solutions for Study Data Exchange Standards" the purpose of which is to solicit input from industry, technology vendors, and other members of the public regarding the advantages and disadvantages of current and emerging open, consensus-based standards for the exchange of regulated study data. FDA also seeks input from stakeholders and other members of the public on this topic and a set of premeeting questions discussed below. 2012-08-14 2012 8 https://www.federalregister.gov/documents/2012/08/14/2012-19748/regulatory-new-drug-review-solutions-for-study-data-exchange-standards-notice-of-meeting-request-for https://www.govinfo.gov/content/pkg/FR-2012-08-14/pdf/2012-19748.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is announcing a meeting entitled "Regulatory New Drug Review: Solutions for Study Data Exchange Standards" the purpose of which is to solicit input from industry, technology vendors, and other members of the...  

Links from other tables